L. Kopper et al., LOSS OF TRANSFORMING GROWTH-FACTOR-BETA-1 REGULATORY ACTIVITY IN HUMAN NON-HODGKIN LYMPHOMAS, Anticancer research, 14(1A), 1994, pp. 119-122
Since TGF beta 1 inhibits the proliferation of normal B-cells, its dis
turbed activity in B cell lymphomas is conceivable. We found high expr
ession of TGF beta 1 mRNA in three human B cell non-Hodgkin lymphoma x
enografts; also, the gene product (in latent form) was detectable in a
ll lymphoma cells. However, on exposing the cells to exogenously activ
ated TGF beta 1, the incorporation of tritiated thymidine decreased in
normal (murine thymocytes, human peripheral mononuclear cells), but n
ot in lymphoma cells. These observations suggest the malfunction of TG
F beta 1 mediated regulatory pathway (e.g. insufficient activation or
receptor expression) which can contribute to the unlimited expansion o
f a lymphoid clone. The opposite expression of c-myc to TGF beta and t
he retained sensitivity to anti-IgM indicate that c-myc and Ig recepto
r can operate independently of TGF beta in the regulation of lymphoid
cell proliferation.